Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.

X Hu; Xavier Montalban; AH Cross; M Habek; S Delgado; M Davydovskaya; BJ Ward; BAC Cree; N Totolyan; R Pingili; L Mancione; R Sullivan; W Su; R Zielman; AD Gupta; K Winthrop

doi:10.1007/s40120-022-00346-8

Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.

X Hu, Xavier Montalban, AH Cross, M Habek, S Delgado, M Davydovskaya, BJ Ward, BAC Cree, N Totolyan, R Pingili, L Mancione, R Sullivan, W Su, R Zielman, AD Gupta, K Winthrop

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

1 Citació (Scopus)

1 Descàrregues (Pure)

Idioma original	Anglès
Pàgines (de-a)	759-762
Nombre de pàgines	4
Revista	Neurology and Therapy
Volum	11
Número	2
DOIs	https://doi.org/10.1007/s40120-022-00346-8
Estat de la publicació	Publicada - de juny 2022

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

Accés al document

10.1007/s40120-022-00346-8Llicència: Creative Commons Reconeixement No Comercial

https://ddd.uab.cat/record/274638

Altres arxius i enllaços

Com citar-ho

Hu, X., Montalban, X., Cross, AH., Habek, M., Delgado, S., Davydovskaya, M., Ward, BJ., Cree, BAC., Totolyan, N., Pingili, R., Mancione, L., Sullivan, R., Su, W., Zielman, R., Gupta, AD., & Winthrop, K. (2022). Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab. Neurology and Therapy, 11(2), 759-762. https://doi.org/10.1007/s40120-022-00346-8

@article{0796d6193bd140149f62766515c68ffc,

title = "Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.",

author = "X Hu and Xavier Montalban and AH Cross and M Habek and S Delgado and M Davydovskaya and BJ Ward and BAC Cree and N Totolyan and R Pingili and L Mancione and R Sullivan and W Su and R Zielman and AD Gupta and K Winthrop",

year = "2022",

month = jun,

doi = "10.1007/s40120-022-00346-8",

language = "English",

volume = "11",

pages = "759--762",

journal = "Neurology and Therapy",

issn = "2193-8253",

publisher = "Adis",

number = "2",

}

Hu, X, Montalban, X, Cross, AH, Habek, M, Delgado, S, Davydovskaya, M, Ward, BJ, Cree, BAC, Totolyan, N, Pingili, R, Mancione, L, Sullivan, R, Su, W, Zielman, R, Gupta, AD & Winthrop, K 2022, 'Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.', Neurology and Therapy, vol. 11, núm. 2, pàg. 759-762. https://doi.org/10.1007/s40120-022-00346-8

TY - JOUR

T1 - Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab.

AU - Hu, X

AU - Montalban, Xavier

AU - Cross, AH

AU - Habek, M

AU - Delgado, S

AU - Davydovskaya, M

AU - Ward, BJ

AU - Cree, BAC

AU - Totolyan, N

AU - Pingili, R

AU - Mancione, L

AU - Sullivan, R

AU - Su, W

AU - Zielman, R

AU - Gupta, AD

AU - Winthrop, K

PY - 2022/6

Y1 - 2022/6

UR - http://europepmc.org/abstract/med/35503396

UR - https://www.scopus.com/pages/publications/85129307271

U2 - 10.1007/s40120-022-00346-8

DO - 10.1007/s40120-022-00346-8

M3 - Article

C2 - 35503396

SN - 2193-8253

VL - 11

SP - 759

EP - 762

JO - Neurology and Therapy

JF - Neurology and Therapy

IS - 2

ER -